MyCelx Technologies Corporation Successful leach testing of PFAS media
17 Avril 2023 - 8:00AM
RNS Non-Regulatory
TIDMMYX
MyCelx Technologies Corporation
17 April 2023
17 April 2023
MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)
Successful leach testing of PFAS media
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the
clean water and clean air technology company, is pleased to
announce recent results from the leach testing of its proprietary
per-fluoroalkyl and poly-fluoroalkyl compounds ("PFAS") remediation
media to EPA-proposed drinking water regulations.
The United States Environment Protection Agency ("EPA") analysis
method, EPA SW-864-1311, confirmed that once the media had been
contaminated with PFAS, the captured PFAS remains permanently in
the media eliminating the risk of PFAS leaching back into the water
stream or the environment. This unique capability is especially
important in solving the problem of safely disposing of
PFAS-contaminated media which is a significant component of the
overall cost of PFAS remediation. Existing disposal options are
costly or have environmentally damaging drawbacks. The ability of
the Company's media to capture and immobilize EPA-targeted PFAS
chemicals within drinking water enables safe and sustainable
disposal of PFAS-contaminated material to solids waste landfills
without the risk of re-contaminating water streams or the
environment.
Background on the Test
Specialized laboratories holding accreditation for PFAS in
drinking water conduct the test and provide the analytical data
confirming whether the PFAS-laden filter media is leaching any of
the EPA-proposed National Primary Drinking Water Regulation PFAS
family chemicals: PFOA, PFOS, PFHxS, PFNA, PFBS and GenX. EPA
Method SW-846 1311, Toxicity Characterization Leaching Procedure
(TCLP) test determines the mobility of organic and inorganic
contaminants in potentially hazardous waste. The leaching process
simulates conditions present in a landfill as liquids percolate
through the solid waste.
PFAS, which stands for per-fluoroalkyl and poly-fluoroalkyl
compounds, are a collection of long-lasting manmade toxic
chemicals, which present a threat to the environment and human
health.
Connie Mixon, CEO, commented:
"This is a positive step forward for our patented PFAS
remediation offering, as it confirms that we no longer need to
incinerate our contaminated media, once the PFAS removal process
has been undertaken. The ability to store in landfill rather than
incinerate has multiple benefits to potential customers, primarily
on cost and environmental grounds.
We continue to believe that PFAS remediation will be a global
growth market and we remain excited about becoming a leading player
in the sector. I look forward to updating all our stakeholders on
further developments with our PFAS offering over the coming
months."
For further information, please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity Limited (Nomad and Sole Broker)
Henry Fitzgerald-O'Connor Tel: +44 20 7523 8000
Gordon Hamilton
Celicourt Communications (Financial PR)
Mark Antelme Tel: +44 20 8434 2754
Jimmy Lea
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAKZGMDFVMGFZM
(END) Dow Jones Newswires
April 17, 2023 02:00 ET (06:00 GMT)
Mycelx Technologies (LSE:MYX)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Mycelx Technologies (LSE:MYX)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024